New HIV research reveals how broadly neutralizing antibodies may transform treatment despite the virus's rapid mutation and ...

Trinity researchers address why people living with HIV remain vulnerable to tuberculosis, pointing to a new metabolic target ...

By Deena Beasley May 11 (Reuters) - Re-engineering an HIV patient's own immune cells to find and destroy the virus succeeded ...

Researchers mapped more than 100 mutations that allow diverse HIV-1 strains to evade broadly neutralizing antibodies.

Broadly neutralizing antibodies (bNAbs) are among the most promising new treatments for HIV, offering the potential to forego traditional daily dose of antiretroviral drugs.

HIV-1 remodels the spatial organization of its co-receptor, CXCR4, on T cell membranes, showing that viral entry requires receptor clustering rather than simple receptor binding.

Delhi's health department is tracing 19,000 HIV patients who dropped out of treatment, launching an outreach initiative to ...

FMA executive Dr Alipate Vaka­mocea said it was more concern­ing that medical professionals were avoiding treatment.

An electronic 96-channel pipette was one of the tools used to scale up and allow the teamto perform over 7,000 parallel experiments that uncovered more than 100 bNAb escapemutations across 15 viral ...

A high-level task force established by the prime minister has agreed to develop a comprehensive rapid assessment and survey methodology to evaluate the potential spread of HIV in the general ...

A historian of medicine told Newsweek: "Disease names are always provisional because they are human constructs." ...

Organisations working to strengthen health systems in Africa, including Cohsasa, are likely to find renewed urgency in the ...